CGM
CGM is a medical device with 32 clinical trials. Currently 8 active trials ongoing. Historical success rate of 86.7%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
86.7%
13 of 15 finished
13.3%
2 ended early
8
trials recruiting
32
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on Insulin
CGM for Management of Type 2 Diabetes in Pregnancy
Digital Health Solutions for Patients With Type 2 Diabetes
Glucose Monitoring Comparison in Primary Care
CGM Experience, Preferences & Blood Glucose Parameters
Clinical Trials (32)
CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on Insulin
CGM for Management of Type 2 Diabetes in Pregnancy
Digital Health Solutions for Patients With Type 2 Diabetes
Glucose Monitoring Comparison in Primary Care
CGM Experience, Preferences & Blood Glucose Parameters
The BAMBI II Study
Glucose Homeostasis, Metabolomics and Pregnancy Outcomes After Bariatric Surgery
Does the Use of Continuous Glucose Monitoring (CGM) in the Immediate Postpartum Period in Women With Pregestational Diabetes Admitted to the Hospital Decrease Hypoglycemic Episodes
Continuous Glucose Monitoring (CGM) in Prediabetes With Community Based Recruitment
Continuous Glucose Monitoring in Prediabetes With Health Education Videos Among Community Health Workers
Glucose Pattern in Infertile Women Receiving Assisted Reproduction Using Continuous Glucose Monitoring
Gestational Lifestyle & Outcomes Wellness
CGM and Lifestyle Changes in Patients With Impaired Glucose Tolerance
Metabolic Monitoring During Therapeutic Hypothermia (Cooling) for Hypoxic Ischaemic Encephalopathy
Using the Visualization for Lifestyle Change in Patients At Risk of Cardiovascular Diseases
Continuous Glucose Monitors (CGM) for Type 2 Diabetes (T2D) Risk Evaluation
The Steno Free Trial: AID to Adults with New-onset of Type 1 Diabetes
A Study to Understand How Continuous Glucose Monitors Impact Eating Behavior
Steno2tech - Continuous Glucose Monitoring and Type 2 Diabetes.
Effect of Patient Management Based on Continuous Continuous Glucose Monitoring on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes and Moderate to Severe Coronary Artery Stenosis
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 32